Home
Baker Bros. Advisors reported a 15.5% stake in Prelude Therapeutics PRLD · 10,295,301 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 15.5%
- Last report
- 23.5% · filed 25/06/13
- Shares held
- 10,295,301 sh
- Class
- Common Stock, $0.0001 par value per share
- Holder
- Baker Bros. Advisors
- Event date
- 26/04/20
- Filed
- 26/04/22
15.5% stake · −8.0pp from the last report
- Stake
- 15.5%
- Last report
- 23.5%
- Since last report
- −8.0pp
Prelude Therapeutics trades, last 26 weeks
What else happened in Prelude Therapeutics around then
Filed or reported within 30 days of the trade day · 03/21~05/20Baker Bros. Advisors's other 5% stake reports
- Baker Bros. Advisors
5% stakeKodiak Sciences
5% stakeKodiak Sciences
KOD
35% stake
22,049,297 sh
35% stake
Filed 09/30
- Baker Bros. Advisors
5% stakeBeOne Medicines
5% stakeBeOne Medicines
ONC
7.8% stake
115,912,814 sh
7.8% stake
Filed 09/16
- Baker Bros. Advisors
5% stakeIdeaya Biosciences
5% stakeIdeaya Biosciences
IDYA
5.2% stake
5,010,030 sh
5.2% stake
Filed 08/14
- Baker Bros. Advisors
5% stakeRevolution Medicines
5% stakeRevolution Medicines
RVMD
5.3% stake
11,443,357 sh
5.3% stake
Filed 08/14
- Baker Bros. Advisors
5% stakeImmatics
5% stakeImmatics
IMTX
7% stake
9,508,565 sh
7% stake
Filed 08/14
